Associate Professor at Hainan Medical University, China
Dr. Pir Muhammad is an accomplished researcher and academician with expertise in analytical chemistry, nanotechnology, and biomedical innovations. He has contributed significantly to scientific advancements through his extensive research in disease biomarker detection, nanocatalysts, and drug delivery systems. Dr. Muhammad is currently an Associate Researcher at Hainan Medical University, China, where he leads cutting-edge research projects aimed at early disease diagnosis and therapeutic interventions. Over the years, he has garnered recognition for his pioneering work in nanotechnology-based medical solutions, publishing numerous high-impact research articles in reputed international journals.
Profile
Orcid
Education
Dr. Pir Muhammad pursued his academic journey with distinction. He earned his Ph.D. in Analytical Chemistry from Nanjing University, China, in 2017 under the supervision of Professor Liu Zhen. Prior to this, he completed his Master of Science in Analytical Chemistry from Abdul Wali Khan University, Mardan, Pakistan, in 2011. His foundational education includes a Bachelor of Science degree from the University of Peshawar, specializing in Chemistry, Zoology, and Statistics. Additionally, he obtained a Bachelor of Education (B.Ed.) from Allama Iqbal Open University, Islamabad. His early education was focused on medical sciences, with an F.Sc. (Pre-Medical) from the Board of Intermediate & Secondary Education, Mardan, Pakistan.
Experience
Dr. Pir Muhammad has amassed extensive academic and research experience. Since September 2022, he has been serving as an Associate Researcher at Hainan Medical University, where he spearheads research in nanomedicine and molecular diagnostics. Before this, he worked as a Postdoctoral Researcher at Henan University, China, from 2018 to 2022, contributing to various biomedical projects under the guidance of Professor Shi Bingyang. His earlier experience includes serving as a high school science teacher in Pakistan from 2011 to 2012. Additionally, he undertook a three-month research internship at the Pakistan Council of Scientific and Industrial Research (PCSIR) in 2011, which laid the foundation for his career in scientific research.
Research Interests
Dr. Pir Muhammad’s research interests are centered around advanced materials and biomedical applications. His key areas of focus include:
- Surface-enhanced Raman spectroscopy (SERS) and molecularly imprinted polymers for biomarker detection to enable early and accurate disease diagnosis.
- Rational design of high-activity nanozymes and the structure-activity relationship of nanozymes, particularly single-atom nanozymes for disease-targeted therapy.
- Development of engineered exosomes for drug delivery and targeted treatment of various diseases, with an emphasis on cancer therapy and regenerative medicine.
Awards
Dr. Pir Muhammad has been recognized for his outstanding contributions to science and research. Notable awards include:
- Hainan Free Trade Port E-Level Talent Award (2023-2028) – Recognizing his excellence in research and academia.
- Chinese Scholarship Council (CSC) Award (2012-2017) – A prestigious scholarship supporting his Ph.D. studies in China.
- Merit Scholarship under Upper FATA Student Quota System (2009-2011) – Awarded for academic excellence in Pakistan.
Publications
Dr. Pir Muhammad has authored numerous high-impact research papers. Some selected publications include:
“Recent advances in nanocatalysis for clean energy and carbon neutral applications.” Fuel (2025), 394, 134924. (Cited by multiple articles in renewable energy research)
“Defect Engineering in Nanocatalysts: From Design and Synthesis to Applications.” Advanced Functional Materials (2024), 2314686. (Highly cited in nanotechnology studies)
“MOF-derived yolk-shell CoN/Co-NC@SiO2 nanozyme with oxidase mimetic activities for colorimetric detection of glutathione.” Microchemical Journal (2024), 201, 110671.
“Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway.” Nano Today (2022), 45, 101530.
“Arsenic prodrug mediated tumor microenvironment modulation platform for synergetic glioblastoma therapy.” ACS Applied Materials & Interfaces (2022), 14(32), 36487-36502.
“Ultrasound-activated nano-TiO2 loaded with temozolomide paves the way for resection of chemoresistant glioblastoma multiforme.” Cancer Nanotechnology (2021), 12, 17.
“Nanotechnology-based early diagnosis of central nervous system (CNS) disorders.” Advanced NanoBiomed Research (2021), 1, 2100008.
Conclusion
Dr. Pir Muhammad stands at the forefront of nanomedicine and analytical chemistry research, contributing significantly to scientific knowledge and technological advancements in healthcare. His extensive experience, high-impact publications, and dedication to translational research underscore his role as a leading figure in biomedical innovation. With ongoing research in disease diagnostics and targeted therapies, he continues to drive meaningful contributions toward improving global healthcare solutions.